-
1
-
-
0037196596
-
High resolution structural studies of complex icosahedral viruses: A brief overview
-
Chiu W, Rixon FJ. High resolution structural studies of complex icosahedral viruses: a brief overview. Virus Res 2002;82:9-17
-
(2002)
Virus Res
, vol.82
, pp. 9-17
-
-
Chiu, W.1
Rixon, F.J.2
-
2
-
-
0030426255
-
Structure and assembly of the virion
-
Gibson W. Structure and assembly of the virion. Intervirology 1996;39:389-400
-
(1996)
Intervirology
, vol.39
, pp. 389-400
-
-
Gibson, W.1
-
3
-
-
0033766850
-
Toward a comprehensive phylogeny for mammalian and avian herpesviruses
-
McGeoch DJ, Dolan A, Ralph AC. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 2000;74:10401-6
-
(2000)
J Virol
, vol.74
, pp. 10401-10406
-
-
McGeoch, D.J.1
Dolan, A.2
Ralph, A.C.3
-
4
-
-
84929281641
-
-
Cambridge University Press; Cambridge, UK
-
Arvin A, Campadelli-Fiume G, Mocarski E, et al. Human herpesviruses biology, therapy, and immunoprophylaxis. Cambridge University Press; Cambridge, UK: 2007
-
(2007)
Human Herpesviruses Biology Therapy and Immunoprophylaxis
-
-
Arvin, A.1
Campadelli-Fiume, G.2
Mocarski, E.3
-
5
-
-
0009447935
-
-
University of Texas Medical Branch at Galveston; Galveston TX USA
-
Whitley RJ. Medical microbiology. University of Texas Medical Branch at Galveston; Galveston, TX, USA: 1996
-
(1996)
Medical Microbiology
-
-
Whitley, R.J.1
-
6
-
-
0036882392
-
Viral proteases
-
Ton L. Viral proteases. Chem Rev 2002;102:4609-26
-
(2002)
Chem Rev
, vol.102
, pp. 4609-4626
-
-
Ton, L.1
-
7
-
-
0030923941
-
Herpesvirus proteases: Targets for novel antiviral drugs
-
Holwerda BC. Herpesvirus proteases: targets for novel antiviral drugs. Anti Res 1997;35:1-21
-
(1997)
Anti Res
, vol.35
, pp. 1-21
-
-
Holwerda, B.C.1
-
8
-
-
0021060645
-
Aciclovir: Mechanism of action, pharmacokinetics, safety and clinical applications
-
Gnann JW Jr, Barton NH, Whitley RJ. Aciclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy 1983;3:275-83
-
(1983)
Pharmacotherapy
, vol.3
, pp. 275-283
-
-
Gnann Jr., J.W.1
Barton, N.H.2
Whitley, R.J.3
-
9
-
-
0024041143
-
Antiviral activity and mechanism of action of ganciclovir
-
Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988;10:S490-4
-
(1988)
Rev Infect Dis
, vol.10
-
-
Matthews, T.1
Boehme, R.2
-
10
-
-
0142126681
-
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections
-
De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 2003;16:569-96
-
(2003)
Clin Microbiol Rev
, vol.16
, pp. 569-596
-
-
De Clercq, E.1
-
11
-
-
0026493737
-
Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus
-
Earnshaw DL, Bacon TH, Darlison SJ, et al. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother 1992;36:2747-57
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 2747-2757
-
-
Earnshaw, D.L.1
Bacon, T.H.2
Darlison, S.J.3
-
12
-
-
0026553933
-
Mechanism of action of foscarnet against viral polymerases
-
Crumpacker CS. Mechanism of action of foscarnet against viral polymerases. Am J Med 1992;92:3S-7
-
(1992)
Am J Med
, vol.92
-
-
Crumpacker, C.S.1
-
13
-
-
4644265355
-
Brivudin (Bromovinyl Deoxyuridine)
-
Susan JK, Therese M, Chapman D, et al. Brivudin (Bromovinyl Deoxyuridine). Drugs 2004;64:2091-7
-
(2004)
Drugs
, vol.64
, pp. 2091-2097
-
-
Susan, J.K.1
Therese, M.2
Chapman, D.3
-
14
-
-
0031753306
-
Cidofovir in the treatment of cytomegaloviral disease
-
Kendle JB, Fan-Havard P. Cidofovir in the treatment of cytomegaloviral disease. Ann Pharmacother 1998;32:1181-92
-
(1998)
Ann Pharmacother
, vol.32
, pp. 1181-1192
-
-
Kendle, J.B.1
Fan-Havard, P.2
-
15
-
-
0031932271
-
Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance
-
Jabs DA, Enger C, Dunn J, et al. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. J Infect Dis 1998;177:770-3
-
(1998)
J Infect Dis
, vol.177
, pp. 770-773
-
-
Jabs, D.A.1
Enger, C.2
Dunn, J.3
-
16
-
-
0032840668
-
Human cytomegalovirus: Challenges opportunities and new drug development
-
Field AK. Human cytomegalovirus: challenges opportunities and new drug development. Antivir Chem Chemother 1999;10:219-32
-
(1999)
Antivir Chem Chemother
, vol.10
, pp. 219-232
-
-
Field, A.K.1
-
18
-
-
24144458260
-
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro
-
Williams-Aziz SL, Hartline CB, Harden EA, et al. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Antimicrob Agents Chemother 2005;49:3724-33
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 3724-3733
-
-
Williams-Aziz, S.L.1
Hartline, C.B.2
Harden, E.A.3
-
19
-
-
12944317148
-
Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro
-
Wan WB, Beadle JR, Hartline C, et al. Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro. Antimicrob Agents Chemother 2005;49:656-62
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 656-662
-
-
Wan, W.B.1
Beadle, J.R.2
Hartline, C.3
-
20
-
-
78049256334
-
Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures
-
Jiang ZG, Cohen J, Marshall LJ, Major EO. Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures. Antimicrob Agents Chemother 2010;54:4723-32
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4723-4732
-
-
Jiang, Z.G.1
Cohen, J.2
Marshall, L.J.3
Major, E.O.4
-
22
-
-
30344486584
-
Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy
-
De Clercq E, Field HJ. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy. Br J Pharmacol 2006;147:1-11
-
(2006)
Br J Pharmacol
, vol.147
, pp. 1-11
-
-
De Clercq, E.1
Field, H.J.2
-
23
-
-
0035018488
-
Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl] guanine
-
Ng TI, Shi Y, Huffaker HJ, et al. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy) butyl] guanine. Antimicrob Agents Chemother 2001;45:1629-36
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 1629-1636
-
-
Ng, T.I.1
Shi, Y.2
Huffaker, H.J.3
-
24
-
-
0025644456
-
In-hibition of human herpesvirus 6 replication by 9-[4-hydroxy-2- (hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds
-
Akesson-Johansson A, Harmenberg J, Wahen B, Linde A. In-hibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother 1990;34:2417-19
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 2417-2419
-
-
Akesson-Johansson, A.1
Harmenberg, J.2
Wahen, B.3
Linde, A.4
-
25
-
-
0023270930
-
Inhibiting effect of (R, S)-9-[4-hydroxy-(hydroxymethyl)butyl]guanine on varicella-zoster virus replica-tion in cell culture
-
Abele G, Karlstrom A, Harmenberg J, et al. Inhibiting effect of (R, S)-9-[4-hydroxy-(hydroxymethyl)butyl]guanine on varicella-zoster virus replica-tion in cell culture. Antimicrob Agents Chemother 1987;31:76-80
-
(1987)
Antimicrob Agents Chemother
, vol.31
, pp. 76-80
-
-
Abele, G.1
Karlstrom, A.2
Harmenberg, J.3
-
26
-
-
0029019758
-
Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus
-
Andrei G, Snoeck R, Reymen D, et al. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis 1995;14:318-29
-
(1995)
Eur J Clin Microbiol Infect Dis
, vol.14
, pp. 318-329
-
-
Andrei, G.1
Snoeck, R.2
Reymen, D.3
-
27
-
-
0029098966
-
Mode of action of [(R)-9-{4-hydroxy-2-(hydroxymethyl)butyl}-guanine] against herpesviruses
-
Lowe DM, Alderton WK, Ellis MR, et al. Mode of action of [(R)-9-{4-hydroxy-2-(hydroxymethyl)butyl}-guanine] against herpesviruses. Antimicrob Agents Chemother 1995;39:1802-8
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1802-1808
-
-
Lowe, D.M.1
Alderton, W.K.2
Ellis, M.R.3
-
28
-
-
9644281600
-
Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections
-
Kern ER, Bidanset DJ, Hartline CB, et al. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob Agents Chemother 2004;48:4745-53
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 4745-4753
-
-
Kern, E.R.1
Bidanset, D.J.2
Hartline, C.B.3
-
29
-
-
0344400941
-
Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells
-
Nassiri MS, Emerson R, Devivar L, et al. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells. Br J Haematol 1996;93:273-9
-
(1996)
Br J Haematol
, vol.93
, pp. 273-279
-
-
Nassiri, M.S.1
Emerson, R.2
Devivar, L.3
-
30
-
-
0028853743
-
Design, synthesis, and antiviral activity of certain 2, 5, 6-trihalo-1-(D-ribofuranosyl) benzimidazoles
-
Townsend LR, Devivar S, Turk M, et al. Design, synthesis, and antiviral activity of certain 2, 5, 6-trihalo-1-(D-ribofuranosyl) benzimidazoles. J Med Chem 1995;38:4098-105
-
(1995)
J Med Chem
, vol.38
, pp. 4098-4105
-
-
Townsend, L.R.1
Devivar, S.2
Turk, M.3
-
32
-
-
0035991720
-
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole-L-riboside with a unique mode of action
-
Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole-L-riboside with a unique mode of action. Antimicrob Agents Chemother 2002;46:2365-72
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2365-2372
-
-
Biron, K.K.1
Harvey, R.J.2
Chamberlain, S.C.3
-
33
-
-
0037225808
-
Human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress
-
Krosky PM, Baek MC, Coen DM. Human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 2003;77:905-14
-
(2003)
J Virol
, vol.77
, pp. 905-914
-
-
Krosky, P.M.1
Baek, M.C.2
Coen, D.M.3
-
34
-
-
0035852743
-
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation
-
Wolf DG, Courcelle CT, Prichard MN, et al. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci USA 2001;98:1895-900
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 1895-1900
-
-
Wolf, D.G.1
Courcelle, C.T.2
Prichard, M.N.3
-
35
-
-
84859868714
-
Leflunomide for cytomegalovirus: Bench to bedside
-
Chacko B, John GT. Leflunomide for cytomegalovirus: bench to bedside. Transpl Infect Dis 2012;14:111-20
-
(2012)
Transpl Infect Dis
, vol.14
, pp. 111-120
-
-
Chacko, B.1
John, G.T.2
-
36
-
-
0029793554
-
A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease
-
Tong L, Qian C, Massariol MJ, et al. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature 1996;383:272-5
-
(1996)
Nature
, vol.383
, pp. 272-275
-
-
Tong, L.1
Qian, C.2
Massariol, M.J.3
-
37
-
-
0029797364
-
Unique fold and active site in cytomegalovirus protease
-
Qiu X, Culp JS, DiLella AG, et al. Unique fold and active site in cytomegalovirus protease. Nature 1996;383:275-9
-
(1996)
Nature
, vol.383
, pp. 275-279
-
-
Qiu, X.1
Culp, J.S.2
Dilella, A.G.3
-
38
-
-
16044368319
-
Three-dimensional structure of human cytomegalovirus protease
-
Shieh HS, Kurumbail RG, Stevens AM, et al. Three-dimensional structure of human cytomegalovirus protease. Nature 1996;383:279-82
-
(1996)
Nature
, vol.383
, pp. 279-282
-
-
Shieh, H.S.1
Kurumbail, R.G.2
Stevens, A.M.3
-
39
-
-
16044364654
-
Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad
-
Chen P, Tsuge H, Almassy RJ, et al. Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad. Cell 1996;86:835-43
-
(1996)
Cell
, vol.86
, pp. 835-843
-
-
Chen, P.1
Tsuge, H.2
Almassy, R.J.3
-
40
-
-
0030995541
-
Crystal structure of varicella-zoster virus protease
-
Qiu X, Janson CA, Culp JS. Crystal structure of varicella-zoster virus protease. Proc Natl Acad Sci USA 1997;94:2874-9
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 2874-2879
-
-
Qiu, X.1
Janson, C.A.2
Culp, J.S.3
-
41
-
-
0030720252
-
Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex
-
Hoog SS, Smith WW, Qiu X. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex. Biochemistry 1997;36:14023-9
-
(1997)
Biochemistry
, vol.36
, pp. 14023-14029
-
-
Hoog, S.S.1
Smith, W.W.2
Qiu, X.3
-
42
-
-
0034711002
-
Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: Regulation of activity and dimerization by conserved structural elements
-
Reiling KK, Pray TR, Craik CS. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements. Biochemistry 2000;39:12796-803
-
(2000)
Biochemistry
, vol.39
, pp. 12796-12803
-
-
Reiling, K.K.1
Pray, T.R.2
Craik, C.S.3
-
43
-
-
80051666040
-
Enzyme inhibition by allosteric capture of an inactive conformation
-
Lee GM, Shahian T, Baharuddin A, et al. Enzyme inhibition by allosteric capture of an inactive conformation. J Mol Biol 2011;411:999-1016
-
(2011)
J Mol Biol
, vol.411
, pp. 999-1016
-
-
Lee, G.M.1
Shahian, T.2
Baharuddin, A.3
-
44
-
-
0026004785
-
The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate
-
Liu FY, Roizman B. The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate. J Virol 1991;65:5149-56
-
(1991)
J Virol
, vol.65
, pp. 5149-5156
-
-
Liu, F.Y.1
Roizman, B.2
-
45
-
-
0025721850
-
A herpesvirus maturational proteinase, assemblin: Identification of its gene, putative active site domain, and cleavage site
-
Welch AR, Woods AS, McNally LM, et al. A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. Proc Natl Acad Sci USA 1991;88:10792-6
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 10792-10796
-
-
Welch, A.R.1
Woods, A.S.2
McNally, L.M.3
-
46
-
-
0020678189
-
Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA
-
Preston VG, Coates JAV, Rixon FJ. Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. J Virol 1983;45:1056-64
-
(1983)
J Virol
, vol.45
, pp. 1056-1064
-
-
Preston, V.G.1
Jav, C.2
Rixon, F.J.3
-
47
-
-
0000707160
-
An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin
-
Corey DR, Craik CS. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin. J Am Chem Soc 1992;114:1784-90
-
(1992)
J Am Chem Soc
, vol.114
, pp. 1784-1790
-
-
Corey, D.R.1
Craik, C.S.2
-
48
-
-
0347093522
-
Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods
-
Khayat R, Batra R, Bebernitz GA, et al. Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods. Biochemistry 2004;43:316-22
-
(2004)
Biochemistry
, vol.43
, pp. 316-322
-
-
Khayat, R.1
Batra, R.2
Bebernitz, G.A.3
-
49
-
-
0024280501
-
Dissecting the catalytic triad of a serine protease
-
Carter P, Wells JA. Dissecting the catalytic triad of a serine protease. Nature 1988;332:564-8
-
(1988)
Nature
, vol.332
, pp. 564-568
-
-
Carter, P.1
Wells, J.A.2
-
50
-
-
0035967516
-
Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease
-
Khayat R, Batra R, Massariol MJ. Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease. Biochemistry 2001;40:6344-51
-
(2001)
Biochemistry
, vol.40
, pp. 6344-6351
-
-
Khayat, R.1
Batra, R.2
Massariol, M.J.3
-
51
-
-
0031004379
-
Dimerization and activation of the herpes simplex virus type 1 protease
-
Schmidt U, Darke PL. Dimerization and activation of the herpes simplex virus type 1 protease. J Biol Chem 1997;272:7732-5
-
(1997)
J Biol Chem
, vol.272
, pp. 7732-7735
-
-
Schmidt, U.1
Darke, P.L.2
-
52
-
-
0029619769
-
Stimulation of the herpes simplex virus type i protease by antichaeotrophic salts
-
Yamanaka G, DiIanni CL, O'Boyle DR, et al. Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts. J Biol Chem 1995;270:30168-72
-
(1995)
J Biol Chem
, vol.270
, pp. 30168-30172
-
-
Yamanaka, G.1
Diianni, C.L.2
O'Boyle, D.R.3
-
53
-
-
0034863016
-
Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease
-
Batra R, Khayat R, Tong L. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease. Nat Struct Biol 2001;8:810-17
-
(2001)
Nat Struct Biol
, vol.8
, pp. 810-817
-
-
Batra, R.1
Khayat, R.2
Tong, L.3
-
54
-
-
0031662305
-
Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease
-
Tong L, Qian C, Massariol MJ. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Nat Struct Biol 1998;5:819-26
-
(1998)
Nat Struct Biol
, vol.5
, pp. 819-826
-
-
Tong, L.1
Qian, C.2
Massariol, M.J.3
-
55
-
-
0032493329
-
Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation
-
LaPlante SR, Aubry N, Bonneau PR. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation. Biochemistry 1998;37:9793-801
-
(1998)
Biochemistry
, vol.37
, pp. 9793-9801
-
-
Laplante, S.R.1
Aubry, N.2
Bonneau, P.R.3
-
56
-
-
0000058254
-
Assembling a herpes virus serine maturational proteinase and new molecular target for antivirals
-
Gibson W, Welch AR, Hall MT. Assembling a herpes virus serine maturational proteinase and new molecular target for antivirals. Perspect Drug Discov 1995;2:413-26
-
(1995)
Perspect Drug Discov
, vol.2
, pp. 413-426
-
-
Gibson, W.1
Welch, A.R.2
Hall, M.T.3
-
57
-
-
15144347039
-
Peptidomimetic inhibitors of the human cytomegalovirus protease
-
Ogilvie W, Bailey M, Poupart MA, et al. Peptidomimetic inhibitors of the human cytomegalovirus protease. J Med Chem 1997;40:4113-35
-
(1997)
J Med Chem
, vol.40
, pp. 4113-4135
-
-
Ogilvie, W.1
Bailey, M.2
Poupart, M.A.3
-
59
-
-
0033531627
-
Characterization of the human cytomegalovirus protease as an induced-fit protease and the implications to the design of mechanism-based peptidyl inhibitors
-
LaPlante SR, Bonneau PR, Aubry N, et al. Characterization of the human cytomegalovirus protease as an induced-fit protease and the implications to the design of mechanism-based peptidyl inhibitors. J Am Chem Soc 1999;21:2974-86
-
(1999)
J Am Chem Soc
, vol.21
, pp. 2974-2986
-
-
Laplante, S.R.1
Bonneau, P.R.2
Aubry, N.3
-
60
-
-
2342650688
-
Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor
-
Marnett AB, Nomura AM, Shimba N, et al. Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. Proc Natl Acad Sci USA 2004;101:6870-5
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 6870-6875
-
-
Marnett, A.B.1
Nomura, A.M.2
Shimba, N.3
-
61
-
-
33645229104
-
One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease
-
Nomura AM, Marnett AB, Shimba N, et al. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease. Biochemistry 2006;45:3572-9
-
(2006)
Biochemistry
, vol.45
, pp. 3572-3579
-
-
Nomura, A.M.1
Marnett, A.B.2
Shimba, N.3
-
62
-
-
34848849027
-
Substrate modulation of enzyme activity in the herpesvirus protease family
-
Lazic A, Goetz DH, Nomura AM, et al. Substrate modulation of enzyme activity in the herpesvirus protease family. J Mol Biol 2007;373:913-23
-
(2007)
J Mol Biol
, vol.373
, pp. 913-923
-
-
Lazic, A.1
Goetz, D.H.2
Nomura, A.M.3
-
63
-
-
69249156893
-
Inhibition of a viral enzyme by a small molecule dimer disruptor
-
Shahian T, Gregory ML, Lazic A. Inhibition of a viral enzyme by a small molecule dimer disruptor. Nat Chem Biol 2009;5:640-6
-
(2009)
Nat Chem Biol
, vol.5
, pp. 640-646
-
-
Shahian, T.1
Gregory, M.L.2
Lazic, A.3
-
64
-
-
79956301430
-
The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro
-
Gantt S, Carlsson J, Ikoma M, et al. The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. Antimicrob Agents Chemother 2011;55:2696-703
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 2696-2703
-
-
Gantt, S.1
Carlsson, J.2
Ikoma, M.3
-
65
-
-
84899067359
-
Nelfinavir inhibits maturation and export of herpes simplex virus 1
-
Kalu NN, Desai PJ, Shirley CM, et al. Nelfinavir inhibits maturation and export of herpes simplex virus 1. J Virol 2014;88:5455-61
-
(2014)
J Virol
, vol.88
, pp. 5455-5461
-
-
Kalu, N.N.1
Desai, P.J.2
Shirley, C.M.3
-
66
-
-
84900303076
-
Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy
-
Gantt S, Cattamanchi A, Krantz E, et al. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy. J Clin Virol 2014;60:127-32
-
(2014)
J Clin Virol
, vol.60
, pp. 127-132
-
-
Gantt, S.1
Cattamanchi, A.2
Krantz, E.3
-
67
-
-
21744445760
-
Design of translactam HCMV protease inhibitors as potent antivirals
-
Borthwick AD. Design of translactam HCMV protease inhibitors as potent antivirals. Med Res Rev 2005;25:427-52
-
(2005)
Med Res Rev
, vol.25
, pp. 427-452
-
-
Borthwick, A.D.1
-
68
-
-
0034676308
-
Design and synthesis of pyrrolidine-5, 5-trans-lactams (5-oxo-hexahydro-pyrrolo[3, 2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1 the alpha-methyl-trans-lactam template
-
Borthwick AD, Angier SJ, Crame AJ, et al. Design and synthesis of pyrrolidine-5, 5-trans-lactams (5-oxo-hexahydro-pyrrolo[3, 2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template. J Med Chem 2000;43:4452-64
-
(2000)
J Med Chem
, vol.43
, pp. 4452-4464
-
-
Borthwick, A.D.1
Angier, S.J.2
Crame, A.J.3
-
69
-
-
1842740407
-
Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine
-
Gerona-Navarro G, Perez de Vega MJ, Garcia-Lopez MT, et al. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine. Bioorg Med Chem Lett 2004;14:2253-6
-
(2004)
Bioorg Med Chem Lett
, vol.14
, pp. 2253-2256
-
-
Gerona-Navarro, G.1
Perez De Vega, M.J.2
Garcia-Lopez, M.T.3
-
70
-
-
17144408696
-
From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors
-
Gerona-Navarro G, Perez de Vega MJ, Garcia-Lopez MT, et al. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors. J Med Chem 2005;48:2612-21
-
(2005)
J Med Chem
, vol.48
, pp. 2612-2621
-
-
Gerona-Navarro, G.1
Perez De Vega, M.J.2
Garcia-Lopez, M.T.3
-
71
-
-
79551495636
-
Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors
-
Perez-Faginas P, Aranda MT, Garcia-Lopez MT, et al. Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors. Bioorg Med Chem 2011;19:1155-61
-
(2011)
Bioorg Med Chem
, vol.19
, pp. 1155-1161
-
-
Perez-Faginas, P.1
Aranda, M.T.2
Garcia-Lopez, M.T.3
-
72
-
-
0141517088
-
Pyrimido[1, 2-b]-1, 2, 4, 5-tetrazin-6-ones as HCMV protease inhibitors: A new class of heterocycles with flavinlike redox properties
-
Di Grandi MJ, Curran KJ, Baum EZ, et al. Pyrimido[1, 2-b]-1, 2, 4, 5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavinlike redox properties. Bioorg Med Chem Lett 2003;13:3483-6
-
(2003)
Bioorg Med Chem Lett
, vol.13
, pp. 3483-3486
-
-
Di Grandi, M.J.1
Curran, K.J.2
Baum, E.Z.3
-
74
-
-
84875782555
-
Cytomegalovirus protease targeted prodrug development
-
Sabit H, Dahan A, Sun J. Cytomegalovirus protease targeted prodrug development. Mol Pharm 2013;10:1417-24
-
(2013)
Mol Pharm
, vol.10
, pp. 1417-1424
-
-
Sabit, H.1
Dahan, A.2
Sun, J.3
-
75
-
-
0031008223
-
Herpes simplex virus DNA replication
-
Boehmer PE, Lehman IR. Herpes simplex virus DNA replication. Annu Rev Biochem 1997;66:347-84
-
(1997)
Annu Rev Biochem
, vol.66
, pp. 347-384
-
-
Boehmer, P.E.1
Lehman, I.R.2
-
76
-
-
3042724532
-
Herpes simplex virus 1 helicase-primase: A complex of three herpes-encoded gene products
-
Crute JJ, Tsurumi T, Zhu LA, et al. Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci USA 1989;86:2186-9
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 2186-2189
-
-
Crute, J.J.1
Tsurumi, T.2
Zhu, L.A.3
-
77
-
-
0031846516
-
Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex
-
Spector FC, Liang L, Giordano H, et al. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex. J Virol 1998;72:6979-87
-
(1998)
J Virol
, vol.72
, pp. 6979-6987
-
-
Spector, F.C.1
Liang, L.2
Giordano, H.3
-
78
-
-
0036111626
-
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
-
Kleymann G, Fischer R, Betz UA, et al. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat Med 2002;8:392-8
-
(2002)
Nat Med
, vol.8
, pp. 392-398
-
-
Kleymann, G.1
Fischer, R.2
Betz, U.A.3
-
79
-
-
84892608050
-
Helicase-primase inhibitor pritelivir for HSV-2 infection
-
Wald A, Corey L, Timmler B, et al. Helicase-primase inhibitor pritelivir for HSV-2 infection. N Engl J Med 2014;370:201-10
-
(2014)
N Engl J Med
, vol.370
, pp. 201-210
-
-
Wald, A.1
Corey, L.2
Timmler, B.3
-
80
-
-
47049098403
-
Herpes simplex virus helicase-primase inhibitors: Recent findings from the study of drug resistance mutations
-
Biswas S, Field HJ. Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations. Antivir Chem Chemother 2008;19:1-6
-
(2008)
Antivir Chem Chemother
, vol.19
, pp. 1-6
-
-
Biswas, S.1
Field, H.J.2
-
81
-
-
84904601629
-
Excellent efficacy and pharmacokinetics have been demonstrated in preclinical and phase I/II studies by AIC316, a novel drug against herpes simplex (HSV) type 1 and 2 (abstract 48)
-
16-29 April Sapporo, Japan
-
Birkmann A, McCormick D, Kropelt D, et al. Excellent efficacy and pharmacokinetics have been demonstrated in preclinical and phase I/II studies by AIC316, a novel drug against herpes simplex (HSV) type 1 and 2 (abstract 48). Abstracts of the 25th International Conference on Antiviral Research; 16-29 April 2012; Sapporo, Japan
-
(2012)
25th International Conference on Antiviral Research
-
-
Birkmann, A.1
McCormick, D.2
Kropelt, D.3
-
82
-
-
0036107516
-
Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
-
Crute JJ, Grygon CA, Hargrave KD, et al. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat Med 2002;8:386-91
-
(2002)
Nat Med
, vol.8
, pp. 386-391
-
-
Crute, J.J.1
Grygon, C.A.2
Hargrave, K.D.3
-
83
-
-
84858162396
-
ASP2151 for the treatment of genital herpes: A randomized, double-blind, placebo-and valaciclovir-controlled, dose-finding study
-
Tyring S, Wald A, Zadeikis N, et al. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo-and valaciclovir-controlled, dose-finding study. J Infect Dis 2012;205:1100-10
-
(2012)
J Infect Dis
, vol.205
, pp. 1100-1110
-
-
Tyring, S.1
Wald, A.2
Zadeikis, N.3
-
84
-
-
77954724450
-
ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicellazoster virus and herpes simplex virus types 1 and 2
-
Chono K, Katsumata K, Kontani T, et al. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicellazoster virus and herpes simplex virus types 1 and 2. J Antimicrob Chemother 2010;65:1733-41
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1733-1741
-
-
Chono, K.1
Katsumata, K.2
Kontani, T.3
-
85
-
-
77149133052
-
In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246
-
Lischka P, Hewlett G, Wunberg T, et al. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother 2010;54:1290-7
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1290-1297
-
-
Lischka, P.1
Hewlett, G.2
Wunberg, T.3
-
86
-
-
0036207969
-
Human cytomegalovirus terminase as a target for antiviral chemotherapy
-
Bogner E. Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev Med Virol 2002;12:115-27
-
(2002)
Rev Med Virol
, vol.12
, pp. 115-127
-
-
Bogner, E.1
-
87
-
-
80055021608
-
The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase
-
Goldner T, Hewlett G, Ettischer N, et al. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol 2011;85:10884-93
-
(2011)
J Virol
, vol.85
, pp. 10884-10893
-
-
Goldner, T.1
Hewlett, G.2
Ettischer, N.3
-
88
-
-
79955544310
-
Report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246
-
Kaul DR, Stoelben S, Cober E, et al. Report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. Am J Transpl 2011;11:1079-84
-
(2011)
Am J Transpl
, vol.11
, pp. 1079-1084
-
-
Kaul, D.R.1
Stoelben, S.2
Cober, E.3
-
89
-
-
77957979861
-
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain
-
Nadal M, Mas PJ, Blanco AG, et al. Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain. Proc Natl Acad Sci USA 2010;14:16078-83
-
(2010)
Proc Natl Acad Sci USA
, vol.14
, pp. 16078-16083
-
-
Nadal, M.1
Mas, P.J.2
Blanco, A.G.3
-
92
-
-
0033824673
-
Proteasome inhibitors: From in vitro uses to clinical trials
-
Rivetta AJ, Gardner RC. Proteasome inhibitors: from in vitro uses to clinical trials. J Pept 2000;6:478-88
-
(2000)
J Pept
, vol.6
, pp. 478-488
-
-
Rivetta, A.J.1
Gardner, R.C.2
-
93
-
-
0034659804
-
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses
-
Schwarz K, de Giuli R, Schmidtke G, et al. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses. J Immunol 2000;164:6147-57
-
(2000)
J Immunol
, vol.164
, pp. 6147-6157
-
-
Schwarz, K.1
De Giuli, R.2
Schmidtke, G.3
-
94
-
-
0029915568
-
The human cytomegalovirus US11 gene product dislocates MHC class i heavy chains from the endoplasmic reticulum to the cytosol
-
Wiertz EJ, Jones TR, Sun L, et al. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996;84:769-79
-
(1996)
Cell
, vol.84
, pp. 769-779
-
-
Wiertz, E.J.1
Jones, T.R.2
Sun, L.3
-
97
-
-
64349096615
-
4-Benzyloxy-gamma-sultone derivatives: Discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus
-
De Castro S, Garćia-Aparicio C, Andrei G, et al. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. J Med Chem 2009;52:1582-91
-
(2009)
J Med Chem
, vol.52
, pp. 1582-1591
-
-
De Castro, S.1
Garćia-Aparicio, C.2
Andrei, G.3
-
101
-
-
80052337277
-
Anartemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities
-
He R, Mott BT, Rosenthal AS, et al. Anartemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. PLoS One 2011;6:e24334
-
(2011)
PLoS One
, vol.6
-
-
He, R.1
Mott, B.T.2
Rosenthal, A.S.3
-
102
-
-
84863718403
-
Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients
-
Pagliara D, Savoldo B. Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients. Curr Opin Infect Dis 2012;25:431-7
-
(2012)
Curr Opin Infect Dis
, vol.25
, pp. 431-437
-
-
Pagliara, D.1
Savoldo, B.2
|